Navigation Links
Rigel Announces Proposed Public Offering of Common Stock
Date:5/25/2011

, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as for muscle disorders.

Forward-Looking Information is Subject to Risk and Uncertainty

Certain of the statements made in this press release are forward looking, such as those, among others, relating to Rigel's expectations regarding the completion of the proposed public offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to whether or not Rigel will be able to raise capital through the sale of shares of common stock, the final terms of the proposed offering, market and other conditions, the satisfaction of customary closing conditions related to the proposed public offering and the impact of general economic, industry or political conditions in the United States or internationally. There can be no assurance that Rigel will be able to complete the proposed public offering on the anticipated terms, or at all. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release.  Additional risks and uncertainties relating to the proposed offering, Rigel and its business can be found under the heading "Risk Factors" in Rigel's Quarterly Report on Form 10-Q filed with the SEC on May 3, 2011 and other filings with the SEC, and in the preliminary prospectus supplement related to the proposed offering to be filed with the SEC on or about the date hereof. Rigel expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
2. Rigel Announces First Quarter Financial Results
3. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
4. Rigel to Present at Three Upcoming Investor Conferences
5. Rigel Announces Participation at Two Investor Conferences
6. Rigel to Present at JP Morgan Healthcare Conference
7. Rigel Announces Third Quarter 2009 Financial Results
8. Rigel Announces Presentations at Two Investor Conferences
9. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
10. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
11. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... Oct. 6 Hill-Rom Holdings, Inc. (NYSE: HRC ... approved enhancements to the Company,s corporate governance policies. ... voting in uncontested elections. The Board has ... majority voting standard for the election of directors in uncontested ...
... Foundation Radiology Group (FRG), the premier provider of ... recently added Shawn Kramer, Director of Client Services, ... 20-year client services veteran, has held customer-care focused ... XO Communications. , As the Director of Client ...
Cached Medicine Technology:Hill-Rom Announces Corporate Governance Enhancements 2Hill-Rom Announces Corporate Governance Enhancements 3Hill-Rom Announces Corporate Governance Enhancements 4Foundation Radiology Group Adds Shawn Kramer, Director of Client Services 2
(Date:4/23/2014)... bottom of Alzheimer,s disease has been a rapidly ... In the latest crook in the research road, ... interaction between proteins associated with the disease. The ... Chemical Neuroscience , could have important implications for ... Nieznanski and colleagues explain that for years, research ...
(Date:4/22/2014)... New Jersey Institute of Technology (NJIT) today to ... launch of the New Jersey Innovation Institute (NJII), ... for business innovation through the leveraging of industry, ... Senator Cory Booker, Panasonic Corp. of North America ... Governor Kim Guadagno, New Jersey Secretary of Higher ...
(Date:4/22/2014)... the last few decades researchers have characterized a set ... and behavior in all types of species, from flies ... identified, but researchers surmise there are more. A team ... of Pennsylvania wondered if big-data approaches could find them. ... by John Hogenesch, PhD, professor of Pharmacology and first ...
(Date:4/22/2014)... April 22, 2014 Researchers at UT Southwestern Medical ... from depression . , A team of ... by which ghrelin (a hormone with natural anti-depressant properties) ... potentially powerful new treatment for depression in the form ... The study, published online in April,s issue of ...
(Date:4/22/2014)... risk of pregnancy among women using a newer method ... 10 times greater over a 10-year period than using ... researchers at Yale University and UC Davis has found. ... Contraception , the study found the higher risk ... the brand name Essure. , "This study provides ...
Breaking Medicine News(10 mins):Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3
... family history of the disease, researchers say , , MONDAY, Dec. ... significant other are more prone to get early screening for prostate ... in Cancer Epidemiology, Biomarkers & Prevention , found that even ... less likely to be screened if they lived alone compared to ...
... RF Technologies(R), a leading,provider of radio frequency identification systems ... Designed to allow,hospitals easier access to the Safe ... of financing, this option is especially helpful,in today,s tight ... pleased to offer a new way for hospitals to ...
... the Federal Reserve announced,its plan to invest up to ... Freddie Mac and Ginnie Mae, mortgage interest rates dropped ... may actually,qualify for these savings. In addition to tighter ... plagued by the nation,s credit,reporting system. , ...
... to the University of Antwerp have developed a new ... of hereditary diseases more quickly and efficiently. By means ... time today − such as screening for hereditary forms ... more rapidly. This finding creates new perspectives for tests ...
... COMPETITION IN MATH,SCIENCE & TECHNOLOGY , , ... , , Sajith M. Wickramasekara of ... Win Team Grand Prize , , ... innovators of tomorrow bravely took on groundbreaking research of life-threatening infections ...
... FRESNO, Calif., Dec. 8 Over 56% of ... concerned that the current,economic downturn will have a ... achieve a healthy weight, according to a survey ... Almost three-quarters (72.2%) of ...
Cached Medicine News:Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 2Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 3Health News:Although Interest Rates Plunge, Credit Reporting System Prevents Many Borrowers From Seizing Opportunities 2Health News:Although Interest Rates Plunge, Credit Reporting System Prevents Many Borrowers From Seizing Opportunities 3Health News:New technique enables faster genetic diagnosis for hereditary diseases 2Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 2Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 3Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 4Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 5Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 6Health News:Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nation's Premier High School Science Competition 7Health News:Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets. 2
... workhorse for the lab, featuring easy-to-use control knobs, ... Product features , , Digital display with ... (W x D) footprint fits on a crowded ... 24-place capacity , Brushless motor provides maintenance-free ...
... and Proteomic users should inquire about ... Preparation capability for run-to-run replication. Compact ... accommodates 4x750 ml up to 4550xg ... throughput screening, research and patient specimen ...
Inquire...
... Oven/Shaker rigidly controls the temperature and ... hybridization and washing steps. This facilitates ... nucleic acids and proteins immobilized on ... radioactive and nonradioactive labeling systems supplied ...
Medicine Products: